A prospective open-label trial; Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after endothelial keratoplasty (DSAEK or DMEK)
Not Applicable
- Conditions
- Bullous keratopathy
- Registration Number
- JPRN-UMIN000027924
- Lead Sponsor
- Department of Ophthalmology, Yokohama Minami Kyosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
patients without bullous keratoplathy, who agree with this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method central foveal thickness preoperatively, and 1, 3, 6, 12 months postoperatively after endothelial keratoplasty
- Secondary Outcome Measures
Name Time Method the best-corrected visual acuity (BCVA), central corneal thickness(CCT), and corneal endothelial cell density(ECD), preoperatively, and 1, 3, 6, 12 months postoperatively after endothelial keratoplasty